Patrick Flochel appointed EY Global Pharmaceutical Leader

  • Share

London, 2 July 2012 - EY is pleased to announce Patrick Flochel has been appointed Global Pharmaceutical Leader, expanding his responsibilities from his current role as Europe, Middle East, India, and Africa (EMEIA) Life Sciences Leader. Patrick will also be part of the leadership of EY’s Global Life Sciences Center team. He replaces Carolyn Buck Luce, who has rotated out of the roles in advance of her retirement from EY at the end of 2012. EY’s Global Life Sciences Center consolidates knowledge and experience from around the globe and provides the high level insight and analysis clients need to adapt to a rapidly changing healthcare environment.

As EMEIA Life Sciences Sector Leader, Patrick has been responsible for coordinating and supporting EY’s relationships with pharmaceutical, biotechnology and medical technology companies in the region, developing and growing a network of professionals active in the sector, and presenting EY’s external point of view.

Patrick comments, “This is a particularly interesting and challenging time for pharmaceutical companies, who are aggressively restructuring and adopting new patient-centric business models in response to a rapidly changing market for their products. I am looking forward to leading EY’s global pharmaceutical sector and supporting our teams and clients around the globe address their critical business issues.” 

Patrick has had a 30-year career in auditing and consulting, starting in 1979 in EY’s Paris office and moving to Brussels in 1989 to lead its EU Policy and Regulation Team providing strategic advisory services to Fortune 500 companies in the industrial and financial sectors. He joined the organization’s Change Management Practice in Paris in 1995 while setting up the French practice’s marketing and communications department and later moved to London as Global Vice-Chair for Business Development. He has also served on various management and leadership positions at EY at global and EMEIA levels.

Glen Giovannetti, Global Life Sciences Leader, says, “Patrick’s experience, as well as his knowledge of our global organization makes him a natural fit for his new role. Patrick will bring continuity to the role as we maintain our focus on growing the life sciences practice globally. I'm looking forward to working even closer with him as his sector responsibilities expand.”

-Ends-

About EY’s Global Life Sciences Center

EY’s Global Life Sciences Center brings together a worldwide team of professionals to help life sciences companies address their challenges at every stage of development. From the emerging biotech or medtech firm to the well-established, global pharmaceutical company, our industry teams bring deep experience in providing assurance, tax, transaction and advisory services. The Center works to anticipate market trends, identify implications and develop points of view on relevant industry issues. Whether it’s forming innovative alliances, improving operations, new regulations or exploring new markets, we can give you a clear perspective on how to drive value in an increasingly complex, competitive and risk-driven environment. It’s how EY makes a difference.

For more information, please visit www.ey.com/progressions or email global.lifesciences@ey.com.

About EY

EY is a global leader in assurance, tax, transaction and advisory services. Worldwide, our 152,000 people are united by our shared values and an unwavering commitment to quality. We make a difference by helping our people, our clients and our wider communities achieve their potential.

EY refers to the global organization of member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst & Young Global Limited, a UK company limited by guarantee, does not provide services to clients. For more information about our organization, please visit www.ey.com.

This news release has been issued by EYGM Limited, a member of the global EY organization that also does not provide any services to clients.